Senolytic activity: selectively induces apoptosis in senescent cells via inhibition of PI3K/AKT/mTOR survival pathway. Anti-inflammatory: inhibits NF-κB signaling. Antioxidant: direct ROS scavenging and Nrf2 activation. SIRT1 activation reported in some models.
Studies have administered: 20mg/kg intermittent (burst dosing) per Mayo protocol extrapolations; human trials 100–1000mg/day being evaluated
Yousefzadeh (2018) EBioMedicine: strongest senolytic activity among 10 flavonoids tested; extended lifespan in aged mice 10–15%. Reduced inflammatory markers in elderly humans in phase 1. Multiple Mayo Clinic trials ongoing 2024.
Well-tolerated in human studies to date; theoretical concern of eliminating some beneficial senescent cells
These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.
Want a Complete Research Monograph?
Our AI can generate a 2,000+ word deep-dive on Fisetin — including full clinical trial summaries, pharmacokinetics, and research frontiers.
Generate Deep Dive in Research Chat